Dxcover ^Companies

Dxcover is a clinical-stage liquid biopsy startup that aims to be a world leader in early cancer detection using artificial intelligence. Their innovative approach combines infrared spectroscopy and circulating pan-omic indicators to identify and diagnose various types of cancers at an early stage. With compelling clinical data showing high accuracy in diagnosing Stage I and Stage II malignancies, Dxcover is making significant strides in the field of cancer diagnostics. Founded in 2016, the company is based in Glasgow, Scotland and is focused on developing a multi-cancer platform, with their first application targeting the earlier diagnosis of brain tumors.